The U.S. is expected to lose its official measles elimination status after a Pan American Health Organization review this week, according to CNBC. More than 5,100 measles cases have been reported nationwide in 2026 as of early November, the report says, marking the country's worst outbreak in more than three decades.

A new tool developed by researchers at Johns Hopkins University estimates the 2026 outbreaks have an economic cost of nearly $83 million. That total includes $56 million in public health response costs, almost $25 million in lost productivity and more than $1.8 million in direct medical expenses. The researchers say the tool also estimates that 2025 outbreaks, which involved 2,289 confirmed cases, carried an economic cost of more than $37 million.

The estimates are not a definitive accounting of actual costs, the report notes. Bryan Patenaude, a health economist at the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health, who helped develop the tool, said many people who skipped childhood vaccination or were protected by herd immunity are now reaching adulthood, where they face serious illness, high medical expenses or death.

The tool estimates New York's 48 cases in 2025 cost about $1.1 million. It estimates Texas's 803 cases, the epicenter of the largest U.S. outbreak in 2025, cost nearly $13 million. Costs vary by state because of differences in hospital costs and wages, according to the report.